Passage Bio Inc. (NASDAQ: PASG)
$0.8258
-0.0042 ( -3.40% ) 614.0K
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
Market Data
Open
$0.8258
Previous close
$0.8300
Volume
614.0K
Market cap
$51.27M
Day range
$0.7800 - $0.8960
52 week range
$0.4510 - $1.7900
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Dec 31, 2024 |
| 4 | Insider transactions | 1 | Dec 26, 2024 |
| 4 | Insider transactions | 1 | Dec 11, 2024 |
| 4 | Insider transactions | 1 | Dec 06, 2024 |
| 4 | Insider transactions | 1 | Nov 27, 2024 |
| 8-k | 8K-related | 46 | Nov 13, 2024 |
| 10-q | Quarterly Reports | 74 | Nov 13, 2024 |
| 8-k | 8K-related | 34 | Oct 24, 2024 |
| 3 | Insider transactions | 2 | Oct 02, 2024 |
| 4 | Insider transactions | 1 | Oct 02, 2024 |